Nitric oxide mediates hepatic cytochrome P450 dysfunction induced by endotoxin

Area of Science:

• Pharmacology
• Biochemistry
• Toxicology

Background:

• Sepsis significantly reduces cytochrome P450 (P450) content and P450-dependent drug metabolism.
• P450 enzymes are crucial for metabolizing various drugs, including opioids and hypnotics.
• Endotoxin-induced nitric oxide (NO) synthesis is hypothesized to mediate these sepsis-related metabolic alterations.

Purpose of the Study:

• To investigate the role of nitric oxide (NO) in sepsis-induced alterations of hepatic drug metabolism.
• To determine if inhibiting NO synthesis can prevent the decrease in P450 content and activity during endotoxemia.

Main Methods:

• Rats were administered bacterial lipopolysaccharides (endotoxin) to induce sepsis.
• Nitric oxide synthase (NOS) was inhibited using aminoguanidine or N(G)-L-monomethyl-arginine.
• Hepatic microsomes were analyzed for total P450 content and the metabolism of ethylmorphine and midazolam.
• Plasma nitrite and nitrate levels were measured as indicators of NO production.

Main Results:

• Endotoxin administration increased plasma nitrite/nitrate, decreased P450 content, and reduced ethylmorphine and midazolam metabolism.
• Inhibition of NO synthesis partially reversed the endotoxin-induced decreases in P450 content and drug metabolism.
• Plasma nitrite/nitrate levels showed a significant negative correlation with P450 content and drug metabolite concentrations.

Conclusions:

• Nitric oxide (NO) significantly contributes to the altered hepatic microsomal metabolism of drugs like ethylmorphine and midazolam during sepsis.
• Targeting NO pathways may offer therapeutic potential for managing drug metabolism disturbances in sepsis.